1. Home
  2. SDGR vs GAB Comparison

SDGR vs GAB Comparison

Compare SDGR & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • GAB
  • Stock Information
  • Founded
  • SDGR 1990
  • GAB 1986
  • Country
  • SDGR United States
  • GAB United States
  • Employees
  • SDGR N/A
  • GAB N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • GAB Investment Managers
  • Sector
  • SDGR Health Care
  • GAB Finance
  • Exchange
  • SDGR Nasdaq
  • GAB Nasdaq
  • Market Cap
  • SDGR 1.7B
  • GAB 1.8B
  • IPO Year
  • SDGR 2020
  • GAB N/A
  • Fundamental
  • Price
  • SDGR $20.32
  • GAB $6.01
  • Analyst Decision
  • SDGR Buy
  • GAB
  • Analyst Count
  • SDGR 7
  • GAB 0
  • Target Price
  • SDGR $28.43
  • GAB N/A
  • AVG Volume (30 Days)
  • SDGR 1.4M
  • GAB 667.8K
  • Earning Date
  • SDGR 08-06-2025
  • GAB 01-01-0001
  • Dividend Yield
  • SDGR N/A
  • GAB 10.91%
  • EPS Growth
  • SDGR N/A
  • GAB N/A
  • EPS
  • SDGR N/A
  • GAB N/A
  • Revenue
  • SDGR $237,917,000.00
  • GAB N/A
  • Revenue This Year
  • SDGR $24.44
  • GAB N/A
  • Revenue Next Year
  • SDGR $22.17
  • GAB N/A
  • P/E Ratio
  • SDGR N/A
  • GAB N/A
  • Revenue Growth
  • SDGR 18.59
  • GAB N/A
  • 52 Week Low
  • SDGR $16.60
  • GAB $4.56
  • 52 Week High
  • SDGR $28.47
  • GAB $5.88
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 51.18
  • GAB 60.36
  • Support Level
  • SDGR $18.75
  • GAB $5.93
  • Resistance Level
  • SDGR $20.37
  • GAB $5.96
  • Average True Range (ATR)
  • SDGR 1.07
  • GAB 0.05
  • MACD
  • SDGR 0.11
  • GAB 0.00
  • Stochastic Oscillator
  • SDGR 96.23
  • GAB 85.71

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About GAB Gabelli Equity Trust Inc. (The)

Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.

Share on Social Networks: